1. Assimina Z, Charilaos K, Fotoula B. Leishmaniasis: An overlooked public health concern. Health Sci J. 2008;2(4):196-205.
2. Ahmadi N, Modiri M, Mamdohi S. First survey of cutaneous leishmaniasis in Borujerd county, western Islamic Republic of Iran. East Mediterr Health J. 2013;19(10):847-853. [
DOI:10.26719/2013.19.10.847] [
PMID]
3. Postigo JAR. Leishmaniasis in the world health organization eastern mediterranean region. Int J Antimicrob Agents. 2010;36(Supp1):S62-65. [
DOI:10.1016/j.ijantimicag.2010.06.023] [
PMID]
4. Livneh A, Youngster I, EI-On Y, Berkovitch M, Abu-Kishk I. The lack of effectiveness of hyperbaric oxygenation as a treatment for Leishmania major in a mouse model. Acta Parasitol. 2015;60(2):345-349. [
DOI:10.1515/ap-2015-0048] [
PMID]
5. Amiri-Dashatan N, Rezaei-Tavirani M, Ahmadi N. A quantitative proteomic and bioinformatics analysis of proteins in metacyclogenesis of Leishmania tropica. Acta Tropica. 2020;202:105227. [
DOI:10.1016/j.actatropica.2019.105227] [
PMID]
6. Amiri-Dashatan N, Koushki M, Ahmadi N. Comparison of gene expression of pyruvate kinase and tryparedoxin peroxidase in metacyclic promastigote forms of Leishmania (L.) tropica and L. major by real-time PCR. Ann Parasitol. 2020;66(1):13-18.
7. He L, He T, Farrar S, Ji L, Ma X. Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species. Cell Physiol Biochem. 2017;44(2):532-553. [
DOI:10.1159/000485089] [
PMID]
8. Nathan C, Cunningham-Bussel A. Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nature Reviews Immunology. 2013;13:349-361. [
DOI:10.1038/nri3423] [
PMID] [
PMCID]
9. Tabrizi F, Seyyed Tabaei S, Ahmadi N, Arefi Oskouie A. A nuclear magnetic resonance- based metabolomic study to identify metabolites differences between Iranian isolates of Leishmania major and Leishmania tropica. Iran J Med Sci. 2020;46:(2-10).
10. Saxena A, Lahav T, Holland N, Aggarwal G, Anupama A, Huang Y, et al. Analysis of the Leishmania donovani transcriptome reveals an ordered progression of transient and permanent changes in gene expression during differentiation. Mol Biochem Parasitol. 2007;152(1):53-65. [
DOI:10.1016/j.molbiopara.2006.11.011] [
PMID] [
PMCID]
11. Akopyants NS, Matlib RS, Bukanova EN, Smeds MR, Brownstein BH, Stormo GD, et al. Expression profiling using random genomic DNA microarrays identifies differentially expressed genes associated with three major developmental stages of the protozoan parasite Leishmania major. Mol Biochem Parasitol. 2004;136(1):71-86. [
DOI:10.1016/j.molbiopara.2004.03.002] [
PMID]
12. Torres DC, Adaui V, Ribeiro-Alves M, Romero GAS, Arevalo J, Cupolillo E, et al. Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes. Infect Genet Evol. 2010;10(6):727-733. [
DOI:10.1016/j.meegid.2010.05.006] [
PMID]
13. Cohen-Freue G, Holzer TR, Forney JD, McMaster WR. Global gene expression in Leishmania. Int J Parasitol. 2007;37(10):1077-86. [
DOI:10.1016/j.ijpara.2007.04.011] [
PMID]
14. Mohebali M,Kazemirad E, Hajjaran H, Kazemirad E, Oshaghi MA, Raoofian R, et al. Gene expression analysis of antimony resistance in Leishmania tropica using quantitative real-time PCR focused on genes involved in trypanothione metabolism and drug transport. Arch Dermatol Res. 2019;311(1):9-17. [
DOI:10.1007/s00403-018-1872-2] [
PMID]
15. Lubos E, Loscalzo J, Handy DE. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxidants & redox signaling. 2011;15(7):1957-1997. [
DOI:10.1089/ars.2010.3586] [
PMID] [
PMCID]
16. Andrade JM, Murta SMF. Functional analysis of cytosolic tryparedoxin peroxidase in antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum lines. Parasit & Vectors. 2014;7(406):1-9. [
DOI:10.1186/1756-3305-7-406] [
PMID] [
PMCID]
17. Iyer JP, Kaprakkaden A, Choudhary ML, Shaha C. Crucial role of cytosolic tryparedoxin peroxidase in Leishmania donovani survival, drug response and virulence. Mol Microbiol. 2008;68(2):372-91. [
DOI:10.1111/j.1365-2958.2008.06154.x] [
PMID]
18. Rochette A, Raymond F, Ubeda JM, Smith M, Messier N, Boisvert S, et al. Genome-wide gene expression profiling analysis of Leishmania major and Leishmania infantum developmental stages reveals substantial differences between the two species. BMC genomics. 2008;9(255):1-26. [
DOI:10.1186/1471-2164-9-255] [
PMID] [
PMCID]
19. Moreira W, Legare D, Racine G, Roy G, OuelletteM. Proteomic analysis of metacyclogenesis in Leishmania infantum wild-type and PTR1 null mutant. EuPA Open Proteomics. 2014;4:171-183. [
DOI:10.1016/j.euprot.2014.07.003]
20. Peacock CS, Seeger K, Harris D, Murphy L, Ruiz JC, Quail MA, et al. Comparative genomic analysis of three Leishmania species that cause diverse human disease. nature genetics. 2007;39:839-847. [
DOI:10.1038/ng2053] [
PMID] [
PMCID]